- Home
- TIL vs LGI Comparison
TIL vs LGI Comparison
Compare TIL & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- LGI
- Stock Information
- Founded
- TIL 2018
- LGI 2004
- Country
- TIL United States
- LGI United States
- Employees
- TIL N/A
- LGI N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- LGI
- Sector
- TIL Health Care
- LGI
- Exchange
- TIL Nasdaq
- LGI Nasdaq
- Market Cap
- TIL 230.1M
- LGI 210.5M
- IPO Year
- TIL 2021
- LGI N/A
- Fundamental
- Price
- TIL $31.69
- LGI $17.05
- Analyst Decision
- TIL Buy
- LGI
- Analyst Count
- TIL 5
- LGI 0
- Target Price
- TIL $119.00
- LGI N/A
- AVG Volume (30 Days)
- TIL 263.6K
- LGI 41.1K
- Earning Date
- TIL 08-12-2025
- LGI 01-01-0001
- Dividend Yield
- TIL N/A
- LGI 7.10%
- EPS Growth
- TIL N/A
- LGI N/A
- EPS
- TIL N/A
- LGI N/A
- Revenue
- TIL N/A
- LGI N/A
- Revenue This Year
- TIL N/A
- LGI N/A
- Revenue Next Year
- TIL N/A
- LGI N/A
- P/E Ratio
- TIL N/A
- LGI N/A
- Revenue Growth
- TIL N/A
- LGI N/A
- 52 Week Low
- TIL $9.85
- LGI $12.66
- 52 Week High
- TIL $92.00
- LGI $16.68
- Technical
- Relative Strength Index (RSI)
- TIL 60.55
- LGI 67.44
- Support Level
- TIL $25.58
- LGI $16.50
- Resistance Level
- TIL $32.76
- LGI $16.77
- Average True Range (ATR)
- TIL 2.55
- LGI 0.18
- MACD
- TIL 0.75
- LGI -0.01
- Stochastic Oscillator
- TIL 89.55
- LGI 92.33
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.